Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- AGX +9.2%, AKER +4.6%, OZRK +0.6%
M&A news:
- SALE +49% (RetailMeNot to be acquired by Harland Clarke Holdings for $11.60 per share in cash)
- PNRA +1% (3G Capital (BRK.B) might make rival bid for PNRA, according to NY Post)
Select metals/mining stocks trading higher:
- MTL +5%, HMY +2.3%, RIO +2%, GOLD +2%, SBGL +1.8%, GFI+1.6%, AU +1.4%, AUY +0.9%
Other news:
- SALE +49% (RetailMeNot to be acquired by Harland Clarke Holdings for $11.60 per share in cash)
- NADL +45.6% (NADL receives 10-year contract from ConocoPhillips Skandinavia AS (COP) for the jack-ups West Elara and West Linus)
- TNXP +40.9% (receives official minutes from its Initial Cross-Disciplinary Breakthrough Meeting held with the FDA)
- MXWL +19.3% (signs stock purchase agreement with SDIC Fund; purchase price is $6.32/share and is anticipated to represent approx 19.9% of co's common stock)
- CBIO +16.3% (achieves key milestone under collaboration with ISU Abxis to advance the Factor IX program; Milestone payment received)
- FPP +13.5% (LeRoy Landhuis discloses 8.29% active stake)
- SDRL +13% (SDRL's NADL receives 10-year contract from ConocoPhillips Skandinavia AS (COP) for the jack-ups West Elara and West Linus)
- IDRA +11.8% (provides update on IMO-2125 trials; enrollment has begun for the Phase 2 portion of the trial with the 8mg dose)
- SVU +6.1% (Supervalu to acquire Unified Grocers for approx $375 mln; expected to be accretive to EPS in the first full fiscal year following closing)
- NTLA +5.5% (announces European Patent Office's Decision to grant CRISPR/Cas9 Genome editing technology patent)
- VEON +3.4% (modestly rebounding following recent declines following offering by Telenor)
- AXON +3.3% (prices 6,742,179 common stock offering at $18.54/share)
- QUOT +3.2% (SALE sympathy)
- COUP +3% (announces the launch of a proposed follow-on public offering of 3,700,000 shares of its common stock; offering includes 91,535 shares to be offered by Coupa and 3,608,465 shares to be offered by certain selling stockholders)
- HOG +1.5% (after spiking in late trade on renewed PE rumor)
- AAL +1% (reports March traffic; raises Q1 unit revenue, margin guidance)
- GRPN +0.8% (SALE sympathy)
Analyst comments:
- PUMP +4% (initiated with a Buy at Goldman, among others)
- AUPH +3.9% (initiated with a Overweight at Cantor Fitzgerald; tgt $14)
- ARCO +3.8% (upgraded to Buy from Underperform at BofA/Merrill)
- YELP +2.6% (upgraded to Overweight from Sector Weight at Pacific Crest)
- WDC +2% (upgraded to Overweight from Neutral at JP Morgan)
- STX +1.4% (upgraded to Buy from Neutral at Longbow)
- RNG +1.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- SBAC +0.6% (upgraded to Buy from Neutral at Guggenheim)
- HES +0.5% (added to US 1 List at BofA/Merrill)